Thymic carcinoma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
Marjan Khan (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thymic carcinoma}} | {{Thymic carcinoma}} | ||
{{CMG}} {{shyam}}; {{AE}} {{ | {{CMG}} {{shyam}}; {{AE}} {{Marjan}} | ||
==Overview== | ==Overview== |
Revision as of 14:22, 24 June 2019
Thymic Carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Thymic carcinoma laboratory findings On the Web |
American Roentgen Ray Society Images of Thymic carcinoma laboratory findings |
Risk calculators and risk factors for Thymic carcinoma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[3]
Overview
There are no diagnostic lab findings associated with thymic carcinoma.
Laboratory Findings
- Laboratory findings consistent with the diagnosis of thymic carcinoma include :
- Low RBC levels
- Abnormal electrolites, liver enzymes, and renal function tests could indicate spread of the carcinoma to other organs
- Presence of anti-acetylcholine receptor antibodies may be found in patients with associated myasthenia gravis[1]
References
- ↑ Kim SH, Koh IS, Minn YK (2015). "Pathologic Finding of Thymic Carcinoma Accompanied by Myasthenia Gravis". J Clin Neurol. 11 (4): 372–5. doi:10.3988/jcn.2015.11.4.372. PMC 4596109. PMID 26320843.